You are here

Article Text

Article menu
Download PDFPDF
Rare disease
Adenosquamous carcinoma of the lacrimal gland
  1. Iype Cherian1,
  2. Sachet Pravat Shrestha2,
  3. Moti Lal Panhani3,
  4. O P Talwar4,
  5. Nikunja Yogi5,
  6. Shiwani Rai6,
  7. Subita Lalchan7,
  8. Cecilia Fernandes5
  1. 1Department of Neurosurgery, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  2. 2Ophthalmology Department, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  3. 3Plastic and Reconstructive Surgery Department, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  4. 4Pathology Department, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  5. 5Department of Surgery, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  6. 6ENT Department, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  7. 7Department of Radiodiagnosis, Manipal College of Medical Sciences, Phulbari, Pokhara, Kaski, Nepal
  1. Correspondence to Iype Cherian, driypecherian{at}gmail.com

Summary

A 48-year-old man presented with proptosis of the left eye, which on excisional biopsy proved to be primary adenosquamous carcinoma of the lacrimal gland. The lesion was excised radically by a limited frontotemporo-orbitozygomatic approach and any further surgeries, such as exenteration, were avoided in view of the patient's wish to preserve the eye and vision. Long-term follow-up is planned to look for any metastasis or recurrence of the tumour. Primary adenosquamous carcinoma of the lacrimal gland is a very rare entity and, following a thorough literature review, only two cases of lacrimal gland adenosquamous carcinoma have been reported so far.

https://doi.org/10.1136/bcr.07.2010.3192

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    View Full Text

    Footnotes

    • Competing interests None.

    • Patient consent Obtained.